Concepedia

Tahsin Khan

TK

10

Publications

3.5K

Citations

10

H-Index

2012

Active since

Affiliations

Harvard University(Current)

Massachusetts General Hospital

Massachusetts Institute of Technology

University of Toronto

Dana-Farber Cancer Institute

Tahsin Khan is an author at Harvard University specializing in medicine, genetics, and biology.

ORCID

Top concepts

Publications per year

2012–2022

10

Publications

10

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

Ryohei Katayama, Alice T. Shaw, Tahsin Khan et al. · Science Translational Medicine · 2012 · 1.3K citations

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Dimitrios Anastasiou, Yimin Yu, William J. Israelsen et al. · Nature Chemical Biology · 2012 · 804 citations · Full text

A genetic mechanism for Tibetan high-altitude adaptation

Felipe Lorenzo, Chad D. Huff, Mikko Myllymäki et al. · Nature Genetics · 2014 · 428 citations · Full text

, , +9

Acquired Resistance to Crizotinib from a Mutation in <i>CD74</i>–<i>ROS1</i>

Mark M. Awad, Ryohei Katayama, Michele McTigue et al. · New England Journal of Medicine · 2013 · 408 citations · Full text

, , +14

Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib

Ryohei Katayama, Luc Friboulet, Sumie Koike et al. · Clinical Cancer Research · 2014 · 285 citations · Full text

Rows per page

1–5 of 10